郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2011作者：Charles Henley; Yuhua Yang; James Davis; Jenny Ying Lin Lu; Sean Morony; Wei Fan; Monica Florio; Banghua Sun; Edward Shatzen; James K Pretorius; William G Richards; David J St Jean; Christopher Fotsch; Jeff D Reagan
阅读更多 →

药效评价Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor.

期刊：Biochemical pharmacology发表年份：2011作者：Junko Imanishi; Yoshiaki Morita; Eiji Yoshimi; Kanae Kuroda; Tomoko Masunaga; Kaoru Yamagami; Masako Kuno; Emi Hamachi; Satoshi Aoki; Fumie Takahashi; Katsuya Nakamura; Susumu Miyata; Yoshitaka Ohkubo; Seitaro Mutoh
阅读更多 →

药效评价Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.

期刊：European journal of pharmacology发表年份：2011作者：Keiji Kusumoto; Hideki Igata; Mami Ojima; Ayako Tsuboi; Mitsuaki Imanishi; Fuminari Yamaguchi; Hiroki Sakamoto; Takanobu Kuroita; Naohiro Kawaguchi; Nobuhiro Nishigaki; Hideaki Nagaya
阅读更多 →

药效评价Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.

期刊：Bioorganic & medicinal chemistry发表年份：2011作者：Bin Zhang; Tangzhi Zhang; Anna W Sromek; Thomas Scrimale; Jean M Bidlack; John L Neumeyer
阅读更多 →